Hui Cheng

3.5k total citations
97 papers, 1.6k citations indexed

About

Hui Cheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hui Cheng has authored 97 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 20 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Hui Cheng's work include RNA modifications and cancer (9 papers), NF-κB Signaling Pathways (7 papers) and Cancer-related molecular mechanisms research (7 papers). Hui Cheng is often cited by papers focused on RNA modifications and cancer (9 papers), NF-κB Signaling Pathways (7 papers) and Cancer-related molecular mechanisms research (7 papers). Hui Cheng collaborates with scholars based in China, United States and Taiwan. Hui Cheng's co-authors include Han Jiang, Jiehong Fang, Timothy J. Larson, Carter Van Waes, Eugene G. Mueller, Peter M. Palenchar, Gary A. Jarvis, Jiong Zou, Guangrong Huang and Zhong Chen and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Analytical Biochemistry.

In The Last Decade

Hui Cheng

84 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Cheng China 23 846 290 273 186 145 97 1.6k
Lei Yu China 24 694 0.8× 157 0.5× 145 0.5× 236 1.3× 140 1.0× 115 1.9k
Sajad Ahmad Dar India 23 627 0.7× 220 0.8× 199 0.7× 264 1.4× 243 1.7× 123 1.8k
Naseem Akhter Saudi Arabia 20 603 0.7× 106 0.4× 155 0.6× 168 0.9× 183 1.3× 98 1.9k
Rabia Khan United States 20 508 0.6× 153 0.5× 354 1.3× 162 0.9× 75 0.5× 54 1.5k
Indranil Chattopadhyay India 21 725 0.9× 166 0.6× 221 0.8× 103 0.6× 108 0.7× 45 1.5k
Jun Feng China 21 692 0.8× 86 0.3× 327 1.2× 163 0.9× 133 0.9× 141 1.6k
Xinyou Xie China 23 703 0.8× 208 0.7× 285 1.0× 280 1.5× 91 0.6× 97 1.6k
Norelle L. Sherry Australia 16 920 1.1× 187 0.6× 641 2.3× 266 1.4× 84 0.6× 57 1.9k
Temduang Limpaiboon Thailand 24 721 0.9× 215 0.7× 289 1.1× 182 1.0× 129 0.9× 85 1.5k
Pachiyappan Kamarajan United States 27 1.3k 1.6× 305 1.1× 269 1.0× 304 1.6× 150 1.0× 51 2.6k

Countries citing papers authored by Hui Cheng

Since Specialization
Citations

This map shows the geographic impact of Hui Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Cheng more than expected).

Fields of papers citing papers by Hui Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Cheng. The network helps show where Hui Cheng may publish in the future.

Co-authorship network of co-authors of Hui Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Cheng. A scholar is included among the top collaborators of Hui Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Cheng. Hui Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yujuan, Xiaoqing Li, Lu Zhang, et al.. (2025). Telitacicept plus low-dose mycophenolate mofetil in the treatment of IgA nephropathy: a retrospective study. Clinical and Experimental Medicine. 25(1). 287–287.
2.
3.
Shi, Jin, et al.. (2024). B3GALT4 modulates tumor progression and autophagy by AKT/mTOR signaling pathway in breast cancer. Discover Oncology. 15(1). 488–488. 1 indexed citations
4.
5.
6.
Chen, Bijuan, Hui Cheng, Chun-Ping Huang, et al.. (2024). Identification of prognostic signatures in remnant gastric cancer through an interpretable risk model based on machine learning: a multicenter cohort study. BMC Cancer. 24(1). 547–547. 3 indexed citations
7.
Cheng, Hui, et al.. (2023). Noise Spectral of GML Noise and GSR Behaviors for FGLE with Random Mass and Random Frequency. Fractal and Fractional. 7(2). 177–177. 3 indexed citations
8.
Cheng, Hui, et al.. (2022). Stochastic behaviors of an improved Gompertz tumor growth model with coupled two types noise. Heliyon. 8(11). e11574–e11574. 2 indexed citations
9.
Cheng, Hui, et al.. (2021). Stochastic resonance for a Jerk oscillator with a generalized Mittag-Leffler noise. Chinese Journal of Physics. 77. 1997–2013. 1 indexed citations
10.
Zhang, Ting, Ying Zhou, Jun Guan, & Hui Cheng. (2021). Circ_0058058 Knockdown Inhibits Acute Myeloid Leukemia Progression by Sponging miR-4319 to Regulate EIF5A2 Expression. Cancer Biotherapy and Radiopharmaceuticals. 38(10). 738–748. 11 indexed citations
11.
Yang, Xinping, Hui Cheng, Jianhong Chen, et al.. (2019). Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways. Cancer Immunology Research. 7(11). 1760–1774. 26 indexed citations
12.
Xiao, Roy, Yi An, Wenda Ye, et al.. (2019). Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV− and HPV+ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy. Clinical Cancer Research. 25(21). 6463–6474. 25 indexed citations
13.
Zhang, Jialing, Chien‐Jen Chen, Xinping Yang, et al.. (2018). Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers. Cancer Research. 78(16). 4613–4626. 35 indexed citations
14.
Eytan, Danielle F., Adeeb Derakhshan, Ayman Saleh, et al.. (2016). SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2. Cancer Research. 76(18). 5442–5454. 56 indexed citations
15.
Mohan, Suresh, Robert Vander Broek, Danielle F. Eytan, et al.. (2015). MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 21(17). 3946–3956. 54 indexed citations
16.
Bian, Yansong, Robert Vander Broek, Bradford Hall, et al.. (2013). PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer. Clinical Cancer Research. 19(14). 3808–3819. 66 indexed citations
17.
Cheng, Hui, et al.. (2012). The impact of delivery mode on postpartum stress urinary incontinence in primiparas: a meta-analysis. Neurourology and Urodynamics. 1 indexed citations
18.
Zhang, Xiuming, et al.. (2010). [Regulation and mechanism of Notch signaling pathway in small cell lung cancer].. PubMed. 39(2). 95–9. 5 indexed citations
19.
Swanson, Karen V., et al.. (2008). Structural Requirements for Monoclonal Antibody 2-1-L8 Recognition of Neisserial Lipooligosaccharides. Hybridoma. 27(2). 71–79. 10 indexed citations
20.
Wang, C. C. & Hui Cheng. (1984). The deoxyribonucleoside phosphotransferase of Trichomonas vaginalis. Federation Proceedings. 43(3). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Yu Breakdown of academic impact, for papers by Sajad Ahmad Dar Breakdown of academic impact, for papers by Naseem Akhter Breakdown of academic impact, for papers by Rabia Khan Breakdown of academic impact, for papers by Indranil Chattopadhyay Breakdown of academic impact, for papers by Jun Feng Breakdown of academic impact, for papers by Xinyou Xie Breakdown of academic impact, for papers by Norelle L. Sherry Breakdown of academic impact, for papers by Temduang Limpaiboon Breakdown of academic impact, for papers by Pachiyappan Kamarajan
Rankless by CCL
2026